Jeffrey Stein
About Jeffrey Stein
Jeffrey Stein: President and CEO
Jeffrey Stein is currently the President and Chief Executive Officer. His leadership is characterized by a strong background in both scientific research and executive management. Stein's current role places him at the helm of strategic organizational direction and growth.
Jeffrey Stein's Leadership at Trius Therapeutics
Jeffrey Stein previously served as the CEO of Trius Therapeutics. During his tenure, he led the development of tedizolid, an antibacterial drug that has gained significant attention in the pharmaceutical industry. Stein's efforts in guiding Trius Therapeutics underscore his expertise in drug development and executive leadership.
Venture Partner and Kauffman Fellow at Sofinnova Ventures
Jeffrey Stein has notable experience as a Venture Partner and Kauffman Fellow with Sofinnova Ventures. This role involved him in venture capital, where he focused on funding and developing start-up companies in the life sciences sector. His time at Sofinnova Ventures highlights his ability to bridge science and business.
Co-founder and CSO of Quorex Pharmaceuticals
Jeffrey Stein co-founded Quorex Pharmaceuticals and served as its Chief Scientific Officer. Quorex Pharmaceuticals was a biotechnology company that focused on antimicrobial treatments. The company was acquired by Pfizer in 2005, marking a significant milestone in Stein’s career as a scientist and entrepreneur.
Jeffrey Stein's Postdoctoral and Graduate Research
Jeffrey Stein conducted postdoctoral research as an Alexander Hollaender Distinguished Postdoctoral Fellow at the California Institute of Technology. He completed his graduate work as a NASA Graduate Student Researcher Fellow at the University of California, San Diego. These fellowships underline his strong foundation in scientific research and innovation.
Director of Ideaya Biosciences
Jeffrey Stein currently serves as a Director of Ideaya Biosciences, where he also chairs the compensation committee. His role at Ideaya Biosciences involves providing strategic oversight and governance, leveraging his extensive experience in the biosciences industry.
Founding Chairman and President of the Antimicrobials Working Group
Jeffrey Stein is the Founding Chairman and President of the Antimicrobials Working Group, an organization dedicated to advancing the development of antimicrobial therapies. His leadership in this group reflects his commitment to addressing critical challenges in public health through collaborative industry efforts.